STOCK TITAN

Senseonics (SENS) expands $140M loan deal with Hercules and issues warrants

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Senseonics Holdings, Inc. amended its existing term loan facility with Hercules Capital, expanding access to up to $140.0 million in senior secured term loans. The structure now includes a previously funded $35.0 million initial loan, a $10.0 million Tranche 2 loan and a $10.0 million Tranche 3A loan that the company expects to be funded at the Second Amendment closing on May 6, 2026, plus additional future tranches subject to milestones.

The loans bear interest at the greater of the prime rate plus 2.40% or 9.90% annually and mature on September 3, 2029, with an interest-only period potentially lasting until maturity if a specified 2025 milestone is met. Senseonics will pay a $100,000 facility fee, a $100,000 amendment fee, tiered prepayment penalties, and extra facility fees on later tranches.

In connection with each funded tranche, the company will issue additional stock purchase warrants exercisable for a number of common shares equal to 2.0% of the funded loan amount divided by the three-day volume-weighted average share price, adding potential future equity dilution alongside increased debt capacity.

Positive

  • None.

Negative

  • None.

Insights

Senseonics adds long-dated debt capacity and warrant-linked dilution via a $140M amended loan facility.

The amended agreement with Hercules Capital provides up to $140.0 million in senior secured term loans, including an expected near-term funding of the $10.0 million Tranche 2 and $10.0 million Tranche 3A loans on May 6, 2026. The facility matures on September 3, 2029 and carries an interest rate floor of 9.90%, reflecting the lender’s risk pricing.

Debt service is eased initially through interest-only payments until at least October 1, 2028, and potentially to maturity if the 2025 Tranche 3B milestone is met. This structure supports near-term liquidity but concentrates principal repayments later in the term and at a relatively high interest cost.

In addition to a $100,000 facility fee, a $100,000 amendment fee and tiered prepayment penalties, the agreement includes warrants covering 2.0% of each funded tranche based on a three-day volume-weighted average share price. These warrants introduce incremental potential equity dilution that will depend on actual drawdowns and future stock performance. Subsequent filings may provide more detail on milestone achievement and tranche utilization.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Total term loan capacity $140.0 million Maximum senior secured term loans under amended agreement
Initial term loan funded $35.0 million Previously funded initial tranche
Tranche 2 loan $10.0 million To be funded at Second Amendment closing
Tranche 3A loan $10.0 million Expected funding at Second Amendment closing
Interest rate floor 9.90% annually Greater of prime + 2.40% or 9.90%
Maturity date September 3, 2029 Final maturity of loans under amended facility
Upfront facility and amendment fees $200,000 total $100,000 facility fee and $100,000 amendment fee at closing
Warrant coverage 2.0% of funded amount Common stock warrant coverage per funded tranche
senior secured term loans financial
"make available to Senseonics up to $140.0 million in senior secured term loans"
A senior secured term loan is a long‑term bank-style loan that a company must repay on a set schedule and that is backed by specific assets as collateral; “senior” means it gets paid before other debts if the borrower runs into trouble. For investors, these loans matter because their collateral and priority typically reduce the risk of loss compared with unsecured or junior debt, while the fixed repayment plan and contract terms influence a company’s cash flow, interest burden and financial flexibility—think of it like a mortgage on a business asset that lenders can claim first if payments stop.
Maturity Date financial
"The loans under the Amended Loan Agreement mature on September 3, 2029 (the “Maturity Date”)."
The maturity date is the specific day when a loan, bond, or investment reaches its full term and the borrower must repay the borrowed amount in full. It is important for investors because it indicates when they will receive their initial money back and can plan their future financial steps accordingly. Think of it as the due date for a loan or the day a gift card or coupon expires.
interest-only payments financial
"Borrowings under the Amended Loan Agreement are repayable in monthly interest-only payments through (a) October 1, 2028"
A loan payment plan where the borrower pays only the interest charge for a set period, leaving the original loan amount unchanged until later. For investors, this matters because it can boost short-term cash flow and lower default risk early on, but it also concentrates repayment or raises future payments later, which can increase credit and refinancing risk for lenders and holders of related securities—think of a lease that postpones paying down the car’s price.
prepayment fee financial
"subject to a prepayment fee equal to (a) 3.0% of the principal amount being prepaid"
volume-weighted average price financial
"divided by the exercise price equal to the three-day volume-weighted average price of the Company’s common stock"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
forward-looking statements regulatory
"Forward-Looking Statements This on contains forward-looking statements made in reliance upon the safe harbor provisions"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
false 0001616543 0001616543 2026-05-01 2026-05-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 1, 2026

 

SENSEONICS HOLDINGS, INC.
(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-37717   47-1210911
(State or Other
Jurisdiction of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

20451 Seneca Meadows Parkway
Germantown, MD 20876-7005
(Address of Principal Executive Office) (Zip Code)

 

Registrant's telephone number, including area code: (301) 515-7260

 

Not Applicable

Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.001 par value SENS Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On May 1, 2026, Senseonics Holdings, Inc. (the “Company”) together with several of its wholly-owned subsidiaries (collectively, “Senseonics”) entered into a Second Amendment to Loan and Security Agreement (the “Second Amendment”) with the several financial institutions or entities party thereto (collectively, the “Lenders”) and Hercules Capital, Inc., a Maryland corporation (the “Agent”), in its capacity as administrative agent and collateral agent for itself and the Lenders, which further amends the Company’s existing Loan and Security Agreement, dated as of September 8, 2023, as previously amended by the First Amendment to Loan and Security Agreement, dated as of September 3, 2025 (as further amended, the “Amended Loan Agreement”), by and among Senseonics, certain of the Lenders and the Agent.

 

Pursuant to the Amended Loan Agreement, the Lenders have agreed to make available to Senseonics up to $140.0 million in senior secured term loans, consisting of (i) an initial term loan of $35.0 million, which was previously funded, (ii) a term loan of $10.0 million to be funded at the closing of the Second Amendment (the “Tranche 2 Loan”), (iii) four additional tranches of term loans in the amounts of up to $10.0 million (the “Tranche 3A Loan”), $10.0 million (the “Tranche 3B Loan”), $15.0 million (the “Tranche 4 Loan”) and uncommitted $60.0 million (the “Tranche 5 Loan”), respectively, which will become available to Senseonics upon Senseonics’ satisfaction of certain terms and conditions set forth in the Amended Loan Agreement. The loans under the Amended Loan Agreement mature on September 3, 2029 (the “Maturity Date”). The Company expects both the Tranche 2 Loan and Tranche 3A Loan to be funded at the closing of the Second Amendment, which is scheduled to be May 6, 2026 (the “Amendment Closing Date”), subject to customary closing conditions.

 

The loans under the Amended Loan Agreement bear interest at an annual rate equal to the greater of (i) the prime rate as reported in The Wall Street Journal plus 2.40% and (ii) 9.90%. Borrowings under the Amended Loan Agreement are repayable in monthly interest-only payments through (a) October 1, 2028 and (b) if Senseonics satisfies the 2025 Tranche 3B Milestone (as defined in the Amended Loan Agreement), the Maturity Date. After the interest-only payment period, borrowings under the Amended Loan Agreement are repayable in equal monthly payments of principal and accrued interest until the Maturity Date.

 

At Senseonics’ option, Senseonics may prepay all or any portion of the outstanding borrowings under the Amended Loan Agreement, subject to a prepayment fee equal to (a) 3.0% of the principal amount being prepaid if the prepayment occurs within one year of the Amendment Closing Date, (b) 2.0% of the principal amount being prepaid if the prepayment occurs during the second year following the Amendment Closing Date, and (c) 1.00% of the principal amount being prepaid if the prepayment occurs more than two years after the Amendment Closing Date and prior to the Maturity Date. In addition, a $100,000 facility fee and a $100,000 amendment fee are payable on the Amendment Closing Date and Senseonics will pay additional facility fees in the amount of 0.50% of any drawn Tranche 3B Loan, or in the amount of 1.00% of any drawn Tranche 4 Loan or Tranche 5 Loan.

 

Pursuant to the Amended Loan Agreement, the Company agreed to issue additional warrants (the “Additional Warrants”) in substantially the same form as the warrants issued in connection with the initial term loan upon the funding of the Tranche 2 Loan, Tranche 3A Loan, Tranche 3B Loan, Tranche 4 Loan and Tranche 5 Loan. The Additional Warrants may be exercised through the earlier of (i) the seventh anniversary of the applicable issuance date and (ii) the consummation of certain acquisition transactions involving the Company, as set forth in such Additional Warrants. The number of shares of the Company’s common stock for which the Additional Warrants are exercisable and the associated exercise price are subject to certain customary proportional adjustments for fundamental events, including stock splits and reverse stock splits, as set forth in the Additional Warrants. The Additional Warrants would be exercisable for an aggregate number of shares of the Company’s common stock equal to 2.0% of the funded loan amount divided by the exercise price equal to the three-day volume-weighted average price of the Company’s common stock prior to the issuance date of such Additional Warrants.

 

The foregoing descriptions of the Amended Loan Agreement and the Additional Warrants contained herein do not purport to be complete and are qualified in their entirety by reference to the full text of the Amended Loan Agreement, which is expected to be filed at the time of the Company’s Quarterly Report on 10-Q for the second quarter 2026, and the form of Warrant Agreement, which was filed as Exhibit 10.1 to the Form 8-K filed by the Company on September 11, 2023, and incorporated herein by reference.

 

 

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information included under Item 1.01 above is incorporated by reference into this Item 2.03.

 

Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements include all statements that do not relate solely to historical or current facts, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. These forward-looking statements include statements related to the anticipated closing of the Amended Loan Agreement, and the availability of funding of future tranches of term loans under the Amended Loan Agreement. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including the uncertainties related to the Company’s ability to satisfy milestones for additional borrowing under the Amended Loan Agreement and compliance with covenants thereunder, market conditions and such other risks and uncertainties described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 2, 2026, and other filings the Company makes with the SEC from time to time. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Current Report on Form 8-K. The Company undertakes no duty to update such information except as required under applicable law.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
10.1   Form of Warrant (incorporated herein by reference to Exhibit 10.2 the Company’s Current Report on Form 8-K filed with the SEC on September 11, 2023).
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

* Filed herewith.
   
** Furnished herewith

 

  # Certain information has been omitted from this document in accordance with Regulation S-K, Item 601(b)(10).

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 4, 2026 SENSEONICS HOLDINGS, INC.
 
  By: /s/ Rick Sullivan
  Name: Rick Sullivan
  Title: Chief Financial Officer

 

 

 

FAQ

What did Senseonics (SENS) change in its loan agreement with Hercules Capital?

Senseonics amended its term loan agreement with Hercules Capital to access up to $140.0 million in senior secured term loans. The structure now includes multiple tranches, extended interest-only payments and added warrant coverage tied to each funded tranche, altering both its debt and potential equity profile.

How much total borrowing capacity does Senseonics (SENS) have under the amended loan?

The amended agreement provides up to $140.0 million in senior secured term loans. This includes a previously funded $35.0 million initial loan, a $10.0 million Tranche 2 loan, a $10.0 million Tranche 3A loan, and several additional tranches that become available upon meeting specified conditions.

What are the key interest and maturity terms of Senseonics’ amended loan facility?

Loans under the amended facility bear interest at the greater of the prime rate plus 2.40% or 9.90% annually. The debt matures on September 3, 2029, with interest-only payments through at least October 1, 2028 and potentially through maturity if a 2025 performance milestone is satisfied.

What fees will Senseonics (SENS) pay in connection with the amended loan agreement?

Senseonics will pay a $100,000 facility fee and a $100,000 amendment fee at the amendment closing. It will also owe prepayment fees of 3.0%, 2.0% or 1.0% of prepaid principal depending on timing, plus additional facility fees on any drawn Tranche 3B, Tranche 4 or Tranche 5 loans.

How do the new warrants in the Senseonics (SENS) loan amendment work?

For each funded tranche, Senseonics will issue additional warrants exercisable for common shares equal to 2.0% of the funded loan amount divided by the three-day volume-weighted average share price before issuance. These warrants are exercisable for up to seven years or until certain acquisition transactions occur.

When does Senseonics expect additional loan funding from the amended facility?

The company expects the $10.0 million Tranche 2 loan and the $10.0 million Tranche 3A loan to fund at the Second Amendment closing scheduled for May 6, 2026. Future tranches, including Tranche 3B, Tranche 4 and Tranche 5, depend on meeting terms and conditions in the loan agreement.

Filing Exhibits & Attachments

3 documents